Skip to main content

Cel Sci Corp

CVM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000725363

In the last 90 days, Cel Sci Corp insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $2.08M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Cel Sci Corp changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of CVM: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders7664−12
Shares5.86M5.64M−211.3K (−3.6%)
Value$13.8M$13.1M−$665.6K (−4.8%)

New holders (6)

Institutions that held Cel Sci Corp at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to CVM in Q1 2023
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP99,703$231.0K0.02%
Benedetti & Gucer, Inc.38,971$90.0K0.05%
D. E. Shaw & Co., Inc.33,216$77.1K0.00%
Creative Planning26,825$62.2K0.00%
Chilton Capital Management LLC6$140.00%
Householder Group Estate & Retirement Specialist, LLC211$00.00%

Sold out (18)

Institutions that held Cel Sci Corp at the end of Q4 2022 and filed for Q1 2023 without it.